source
- Biopharma needs to reward scientists' judgmentIt’s not enough for organizations to want scientists to think like entrepreneurs. They have to incentivize and reward for that behavior.BioSpace · 1mo ago↗ source
- AstraZeneca invests $2 billion in Summit Therapeutics to advance PD-1xVEGF bispecific ivonescimab with ADC combosAstraZeneca is committing $2 billion to Summit Therapeutics, acquiring a 12% equity stake at a premium to the biotech's closing price. The funding is aimed at accelerating development of the PD‑1xV…